Bouchet S - Search Results

1

Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.

Rousset M, Dutriaux C, Bosco-Lévy P, Prey S, Pham-Ledard A, Dousset L, Gérard E, Bouchet S, Canal-Raffin M, Titier K, Molimard M. Rousset M, et al. Among authors: bouchet s. Clin Chim Acta. 2017 Sep;472:26-29. doi: 10.1016/j.cca.2017.07.012. Epub 2017 Jul 12. Clin Chim Acta. 2017. PMID: 28709799

2

High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose.

Titier K, Bouchet S, Péhourcq F, Moore N, Molimard M. Titier K, et al. Among authors: bouchet s. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 May 5;788(1):179-85. doi: 10.1016/s1570-0232(02)01003-6. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12668083

3

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

Dulucq S, Bouchet S, Turcq B, Lippert E, Etienne G, Reiffers J, Molimard M, Krajinovic M, Mahon FX. Dulucq S, et al. Among authors: bouchet s. Blood. 2008 Sep 1;112(5):2024-7. doi: 10.1182/blood-2008-03-147744. Epub 2008 Jun 4. Blood. 2008. PMID: 18524988 Free article.

4

The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.

Chaigne-Delalande B, Guidicelli G, Couzi L, Merville P, Mahfouf W, Bouchet S, Molimard M, Pinson B, Moreau JF, Legembre P. Chaigne-Delalande B, et al. Among authors: bouchet s. J Immunol. 2008 Dec 1;181(11):7630-8. doi: 10.4049/jimmunol.181.11.7630. J Immunol. 2008. PMID: 19017951

5

Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS.

Roth O, Spreux-Varoquaux O, Bouchet S, Rousselot P, Castaigne S, Rigaudeau S, Raggueneau V, Therond P, Devillier P, Molimard M, Maneglier B. Roth O, et al. Among authors: bouchet s. Clin Chim Acta. 2010 Feb;411(3-4):140-6. doi: 10.1016/j.cca.2009.10.007. Epub 2009 Oct 22. Clin Chim Acta. 2010. PMID: 19853594

6

A method to measure deferasirox in plasma using HPLC coupled with MS/MS detection and its potential application.

Chauzit E, Bouchet S, Micheau M, Mahon FX, Moore N, Titier K, Molimard M. Chauzit E, et al. Among authors: bouchet s. Ther Drug Monit. 2010 Aug;32(4):476-81. doi: 10.1097/FTD.0b013e3181d8b37f. Ther Drug Monit. 2010. PMID: 20386360

7

[Therapeutic drug monitoring of tyrosine-kinase inhibitors in the treatment of chronic myelogenous leukaemia: interests and limits].

Bouchet S, Royer B, Le Guellec C, Titier K; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Bouchet S, et al. Therapie. 2010 May-Jun;65(3):213-8. doi: 10.2515/therapie/2010017. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699073 Review. French.

8

Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.

Bouchet S, Chauzit E, Ducint D, Castaing N, Canal-Raffin M, Moore N, Titier K, Molimard M. Bouchet S, et al. Clin Chim Acta. 2011 May 12;412(11-12):1060-7. doi: 10.1016/j.cca.2011.02.023. Epub 2011 Feb 21. Clin Chim Acta. 2011. PMID: 21345336

9

Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory.

Bouchet S, Titier K, Moore N, Lassalle R, Ambrosino B, Poulette S, Schuld P, Belanger C, Mahon FX, Molimard M. Bouchet S, et al. Fundam Clin Pharmacol. 2013 Dec;27(6):690-7. doi: 10.1111/fcp.12007. Epub 2012 Oct 31. Fundam Clin Pharmacol. 2013. PMID: 23113675

10

Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications.

Italiano A, Saada E, Cioffi A, Poulette S, Bouchet S, Molimard M, Adenis A, Isambert N, Collard O, Le Cesne A, Maki RG, Bui B. Italiano A, et al. Among authors: bouchet s. Target Oncol. 2013 Dec;8(4):295-300. doi: 10.1007/s11523-012-0243-8. Epub 2012 Dec 21. Target Oncol. 2013. PMID: 23263874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters